Opendata, web and dolomites

ERMOS

Enhanced Resolution MRI Ocular Scanner (ERMOS)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ERMOS" data sheet

The following table provides information about the project.

Coordinator
IMAGING TECHNOLOGY ABRUZZO SRL 

Organization address
address: LOCALITA' BOSCHETTO, NUCLEO DI PILE SNC
city: L AQUILA
postcode: 67100
website: www.univaq.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.imagtech.it
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMAGING TECHNOLOGY ABRUZZO SRL IT (L AQUILA) coordinator 50˙000.00

Map

 Project objective

Enhanced Resolution MRI Ocular Scanner The objective is to show the feasibility of an innovative low cost, high resolution, dedicated MRI scanner to be used for ocular MRI. The main elements of innovation are: a very compact 0.2T magnet, a receiver (HTSRx: High Temperature Superconducting Receiver) composed of an array of 3 orthogonal high Tc superconducting coils that will allow reaching the resolution of high field superconductive “whole body” scanners. The scanner is intended to be used directly in the ophthalmic clinic without the need of sending the patient to a diagnostic imaging department. This changes the clinical path of the patient and is capable of guarantee a better quality. An ophthalmologist with experience of MRI techniques has, in fact, a much better understanding of what the specific images of the eye and of its surrounding mean in the context of the patient clinical picture. The scanner can also be used in the traditional diagnostic imaging departments reducing the queues on the “whole body” apparatuses. ITA srl has done all the development of the apparatus using room temperature receivers and under the Phase 1 project the HTSRx will be tested to show the technological viability of the device. In addition the Phase 1 activity will take care of IP protection and of selecting and contacting clinical/research centers that can associated in a Phase 2 project that has the purpose of demonstrating the diagnostic capabilities of the scanner. Potential users are ophthalmology and diagnostic imaging centres. Given that the percentage of elderly in the population is very high and that eye’s diseases characterize the advanced age the number of these centers is high. At moment most imaging diagnostic centers do not have specific eye coils and, when required, the analysis is performed using head coils that give a relatively poor resolution. Never the less a fixed percentage of patients that goes for eye patholare required to perform an MRI analysis.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ERMOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ERMOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More  

RESHAPE (2019)

Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials

Read More